 NOTE: Patients who are in CR on day 32 proceed to consolidation I. Patients who do not meet protocol definition of CR on day 32 but have no evidence of persistent disease receive vincristine IV weekly until CR is achieved. Patients with persistent marrow disease greater than 5 leukemic blasts andor persistent extramedullary disease or those who do not achieve CR by day 53 are removed from the study. 